Abstract
Purpose
About 5–10 % of breast cancer is due to inherited disease predisposition. Currently known susceptibility genes such as BRCA1 and BRCA2 explain less than 25 % of familial aggregation of breast cancer, which suggests the involvement of additional genetic susceptibility. The SHFM1 [split hand/foot malformation (ectrodactyly) type 1] gene plays an important role in the regulation of gene transcription and cell proliferation and may be involved in the maintenance of genomic integrity. It is a potential candidate for being involved in heritable cancer susceptibility due to its biological function. The SHFM1 protein binds in mammalian cells to the longest conserved region of the BRCA2 protein and is required for BRCA2 stability and function, making a critical contribution to the BRCA2 function in mediating homologous recombination. Therefore, variants in the SHFM1 gene could affect the BRCA2 functionality and be associated with the familial breast/ovarian carcinogenesis.
Methods
We have screened the entire coding region and splice junctions of SHFM1 in affected index cases from 369 Spanish breast/ovarian cancer families for germ line defects, using direct sequencing.
Results
Mutation analysis revealed seven different sequence changes. Based on the in silico analyses of these sequence alterations, as well as their occurrence in cases and controls, none of them, however, were predicted to be pathogenic or associated with cancer susceptibility.
Conclusions
To our knowledge, this is the most comprehensive study reporting the mutation screening of the SHFM1 gene in familial breast/ovarian cancer cases. No evidence for the association with breast/ovarian cancer was observed.
This is a preview of subscription content, log in via an institution to check access.
References
Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22:1790–1797
Crackower MA, Scherer SW, Rommens JM, Hui CC, Poorkaj P, Soder S, Cobben JM, Hudgins L, Evans JP, Tsui LC (1996) Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3–q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet 5:571–579
Ghoussaini M, Pharoah PD (2009) Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncol 5:689–701
Gudmundsdottir K, Lord CJ, Witt E, Tutt AN, Ashworth A (2004) DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells. EMBO Rep 5:989–993
Kojic M, Yang H, Kostrub CF, Pavletich NP, Holloman WK (2003) The BRCA2-interacting protein DSS1 is vital for DNA repair, recombination, and genome stability in Ustilago maydis. Mol Cell 12:1043–1049
Kristensen CN, Bystol KM, Li B, Serrano L, Brenneman MA (2010) Depletion of DSS1 protein disables homologous recombinational repair in human cells. Mutat Res 694:60–64
Li J, Zou C, Bai Y, Wazer DE, Band V, Gao Q (2006) DSS1 is required for the stability of BRCA2. Oncogene 25:1186–1194
Marston NJ, Richards WJ, Hughes D, Bertwistle D, Marshall CJ, Ashworth A (1999) Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol 19:4633–4642
McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O’Connor MJ, Tutt AN, Zdzienicka MZ, Smith GC, Ashworth A (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 66:8109–8115
Ripperger T, Gadzicki D, Meindl A, Schlegelberger B (2009) Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet 17:722–731
Syrjakoski K, Jantti J, Kallioniemi A, Karhu R (2007) Mutations in the BRCA2 interacting DSS1 are not a risk factor for male breast cancer. Int J Cancer 120:444–446
Venza M, Catalano T, Visalli M, Venza I, Lentini M, Curia MC, Mariani-Costantini R, Teti D (2010) Association of the DSS1 c.143G>A polymorphism with skin squamous cell carcinoma. J Invest Dermatol 130:1719–1725
Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW (2008) Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation. J Mol Biol 383:693–712
Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thoma NH, Zheng N, Chen PL, Lee WH, Pavletich NP (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297:1837–1848
Acknowledgments
The present work received financial support by Instituto de Salud Carlos III, Fondo de Investigación Sanitaria (FIS) Research Grants 12/00539, and Sara Gutiérrez-Enríquez and Anna Tenés are funded by Miguel Servet contracts (Instituto de Salud Carlos III, Ministerio de Economía y Competitividad).
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bonache, S., de la Hoya, M., Gutierrez-Enriquez, S. et al. Mutation analysis of the SHFM1 gene in breast/ovarian cancer families. J Cancer Res Clin Oncol 139, 529–532 (2013). https://doi.org/10.1007/s00432-013-1385-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1385-5